Obstructive Sleep Apnea Clinical Trials Database - Free Access to 615 Studies
Access comprehensive clinical trial information for Obstructive Sleep Apnea through Pure Global AI's free database. This collection includes 615 clinical trials across multiple phases including N/A, Phase 4, Phase 2. Currently, 96 trials are actively recruiting participants.
Research for Obstructive Sleep Apnea is being conducted in United States of America, Canada, Brazil and 7+ other countries. Leading sponsors include Fisher and Paykel Healthcare and ResMed. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pressure Relief Algorithm Eval
TheraPAP Adherence Crossover Study
App-Based Optimization of Long-Term CPAP Adherence and Quality of Life
Lifestyle and Physical Activity as Part Of Obstructive Sleep Apnea Treatment
TipTraQ Home Sleep Test Validation Study
DISE-HNS Effect Study
Diurnal Evaluation of OSA Upper Airway Collapsibility and Muscle Responsiveness
Lifestyle Intervention for Obstructive Sleep Apnea in Women
Effectiveness of Stellate Ganglion Block for the Treatment of Obstructive Sleep Apnea
Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC)
The Adherence of Proactive Sleep Apnea Therapy
Metabolic Endpoints for Obstructive Sleep Apnea Following Twelfth Cranial Nerve Stimulation
Trazodone on OSA Endotypes
The Association Between Obstructive Sleep Apnea Severity and Red Blood Cells Indices
A Study of Sex Differences in Neurocirculatory Control
TPAP for Comfort in OSA
Stellate Ganglion Block in Obstructive Sleep Apnea
Efficacy of Stellate Ganglion Block in Obstructive Sleep Apnea
TheraPAP Equivalence Crossover Study
This Research Project Studies the Relationship Between OSA and Nocturia.
Pure Global AI provides free access to 615 clinical trials studying Obstructive Sleep Apnea, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Fisher and Paykel Healthcare, ResMed, University of California, San Diego, among others.